Momenta Pharmaceuticals, Inc. (MNTA)

[floblu14]

Teva shares slide on generic Copaxone fears - Sunday April 19

Excerpts -

Teva Pharmaceutical Industries shares slid five percent on Sunday after U.S. regulators approved a generic version of its top-selling multiple sclerosis drug ....

In a potentially major blow for Teva, the U.S. Food and Drug Administration approved the first generic version of multiple sclerosis drug Copaxone, which accounts for about half the company's profit.

The 20 mg generic drug Glatopa was developed by Sandoz, a unit of Swiss drugmaker Novartis AG, and Momenta Pharmaceuticals Inc, for treating patients with relapsing forms of the neurodegenerative disease.

"That is what the market is worried about. It's the fear of losing Copaxone and the realization that Teva is now under pressure to do something quick," said Excellence Nessuah analyst Gilad Alper.

He said Teva might have to abandon long-term plans of making small deals and developing its own drugs in favor of a major acquisition.

"Mylan would give Teva severe indigestion," said activist shareholder Benny Landa, noting Mylan was a cultural mismatch for Teva. "Teva should not be making $30 billion acquisitions, even if they promise to be accretive in the short term. Teva should be focusing on multiple sub-$10 billion ... acquisitions that will infuse the company with complementary technologies and products."

http://news.yahoo.com/teva-shares-slide-generic-copaxone-fears-130718132--finance.html

I know we've discussed this prior - however, IMHO what is to prevent TEVA from acquiring MNTA (for $50+)??